Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Major facilitator superfamily domain-containing protein 2B (MFSD2B) is a membrane transporter of the major facilitator superfamily, specifically responsible for the export of sphingosine-1-phosphate (S1P), a bioactive sphingolipid, from red blood cells and platelets into the plasma. This export function is crucial for maintaining proper sphingolipid metabolism, normal morphology of red blood cells, and platelet aggregation and thrombus formation. MFSD2B uniquely transports various molecular species of S1P and is distinct from SPNS2, another S1P transporter, both in sequence and tissue specificity. Disruption of MFSD2B leads to sphingolipid accumulation and impaired platelet function, highlighting its potential as a therapeutic target for reducing platelet-dependent thrombotic risk.
Drugs that inhibit MFSD2B would be expected to reduce S1P export from platelets or erythrocytes, which could impair platelet aggregation and thrombus formation. Inhibition may lead to sphingolipid accumulation and platelet dysfunction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Major facilitator superfamily domain-containing protein 2B (MFSD2B).